Exelixis (EXEL) earnings

Earnings (net income) · fiscal 2025
$782.57M

Exelixis (EXEL) reported net income of $782.57M in fiscal 2025 (the year ended December 31, 2025). That is 50.1% higher than the $521.27M of fiscal 2024. Figures as of 18 Nov 2026, 02:07 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
$782.57M
Change on fiscal 2024
+50.1%
Growth, 5 years
+19.5% a year
Highest on record
$782.57Mfiscal 2025
Lowest on record
-$261.30Mfiscal 2014
Fiscal years on record
192009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Exelixis earnings, in more detail

Over the five fiscal years to 2025 net income grew at a compound 19.5% a year. Across the 19 fiscal years on record (2009–2025), the highest was $782.57M in fiscal 2025 and the lowest -$261.30M in fiscal 2014.

History · 19 fiscal years

Earnings (net income) by fiscal year

Exelixis earnings, year by year

Exelixis (EXEL) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025$782.57M 50.1% up
2024$521.27M 150.9% up
2023$207.77M 14.0% up
2022$182.28M 21.1% down
2021$231.06M—
2021$111.78M 65.2% down
2020$321.01M—
2018$690.07M 347.4% up
2017$154.23M—
2016-$70.22M—
2016-$70.22M—
2016-$161.74M—
2015-$161.74M—
2014-$261.30M—
2013-$238.19M—
2012-$145.34M 292.0% down
2011$75.70M—
2010-$92.33M—
2009-$135.22M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Exelixis and comparable companies
CompanyEarnings (net income)Fiscal year
Medpace Holdings MEDP$451.12M2025
Revvity RVTY$241.20M2025
Exelixis EXEL$782.57M2025
Charles River Laboratories International CRL-$144.34M2025
Neurocrine Biosciences NBIX$478.60M2025
Ascendis Pharma ASND-€228.03M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on EXEL

Exelixis, figure by figure

Exelixis (EXEL) overview: price, valuation and scorecardAll health care companies by market value

Exelixis earnings: questions and answers

What is Exelixis's net income?

Exelixis (EXEL) reported net income of $782.57M in fiscal 2025 (the year ended December 31, 2025). That is 50.1% higher than the $521.27M of fiscal 2024.

What is the growth rate of Exelixis's net income?

Over the five fiscal years to 2025 net income grew at a compound 19.5% a year.

What are the highest and lowest net income figures on record for Exelixis?

Across the 19 fiscal years on record (2009–2025), the highest was $782.57M in fiscal 2025 and the lowest -$261.30M in fiscal 2014.

How is Exelixis's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Exelixis (EXEL) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/EXEL/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.